Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · June 12, 2014

Dabigatran Etexilate Associated With Increased Risk for Myocardial Infarction

Journal of the American Heart Association

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Heart Association
Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
J Am Heart Assoc 2014 Jun 06;[EPub Ahead of Print], J Douxfils, F Buckinx, F Mullier, V Minet, V Rabenda, J‐Y Reginster, P Hainaut, O Bruyère, J‐M Dogné

Further Reading